Drug giant Sanofi has formed an unorthodox partnership with a Harvard professor to seek new drugs in areas that have baffled scientists, one of a number of initiatives by Big Pharma to tap outside expertise. The cultures aren’t easy to merge, through, and the Sanofi project has churned through multiple CEOs.